Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.3 USD
-0.26%
Market Closed
Updated:
May 13, 2024
Taro Pharmaceutical Industries Ltd
Gross Profit
|
Taro Pharmaceutical Industries Ltd
Gross Profit Peer Comparison
Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Gross Profit
$293.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-6%
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Gross Profit
$8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-3%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Gross Profit
₪149.5m
|
CAGR 3-Years
218%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
37%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Gross Profit
$3.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Gross Profit
₪79.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Gross Profit
₪3.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Gross Profit?
Gross Profit
293.3m
USD
293.3m
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Gross Profit amounts to 293.3m USD.
What is Taro Pharmaceutical Industries Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
-6%
-6%
Over the last year, the Gross Profit growth was 9%. The average annual Gross Profit growth rates for Taro Pharmaceutical Industries Ltd have been -3% over the past three years , -8% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
